PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023

2 years ago

PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing…

Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

2 years ago

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference…

Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy

2 years ago

Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1, 2023SANTA CLARA, Calif., Aug. 02,…

Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference

2 years ago

WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company…

DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute

2 years ago

ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of…

Jupiter Wellness, Inc. Announces Payment Date for the Distribution of Common Stock of SRM Entertainment, Inc.

2 years ago

JUPITER, FL, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Jupiter Wellness, Inc. (Nasdaq: JUPW) (the “Company” or “Jupiter Wellness”), today announced…

My Crew Doses Inc. Launches Innovative Products and Brands Derived from the Amanita Muscaria Mushroom

2 years ago

Jupiter, Florida--(Newsfile Corp. - August 2, 2023) - My Crew Doses Inc., (the "Company" or "MCD"), an American, PhD-led company…

Advanced Health Intelligence to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd

2 years ago

HighlightsAHI executes a binding exclusive, perpetual license with Shanghai-based Changlin Network Technology Ltd.Changlin is backed by founders with 50 years…

Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy

2 years ago

Company also recently received Rare Pediatric Disease Designation from the FDA for SAT-3153 for the treatment of pediatric patients with…

Medexus Schedules First Fiscal Quarter 2024 Conference Call

2 years ago

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 2, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host…